Trelegy Ellipta

Active Ingredient(s): Fluticasone Furoate + Umeclidinium + Vilanterol
FDA Approved: * September 18, 2017
Category: Lungs (Pulmonary)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Trelegy Ellipta Overview

Vilanterol (INN, USAN) is an ultra-long-acting β2 adrenoreceptor agonist (ultra-LABA), which was approved in May 2013 in combination with fluticasone furoate for sale as Breo Ellipta by GlaxoSmithKline for the treatment of chronic obstructive pulmonary disease (COPD).[1] Vilanterol is available in following combinations: with inhaled corticosteroid fluticasone furoate — fluticasone furoate/vilanterol (trade names Breo Ellipta (U.S.), Relvar Ellipta (EU, RU, JPN)) with muscarinic a...

Read more Trelegy Ellipta Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Trelegy Ellipta Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Fluticasone Furoate + Umeclidinium + Vilanterol
  • Powder: 0.1mg/inh + 0.0625mg/inh + 0.025mg/inh, 100mcg + 62.5mcg + 25mcg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Trelegy Ellipta: (1 result)

Sorted by National Drug Code
  • 0173-0887 Trelegy Ellipta Respiratory (Inhalation) Powder by Glaxosmithkline LLC

Drugs with one or more similar ingredients: (9 results)

Related Trelegy Ellipta Topics:

Anoro Ellipta reactions
Has anyone had an itchy facial rash that got puffy and turned really red, and felt pretty hot? Anoro Ellipta is the only... 3 replies
Side effects of breo ellipta
I was given a sample of breo ellipta for bronchitis.. just bronchitis. I was on it for 2 days when I ended up in the hos... 5 replies

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2018 and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 18 July 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.